Search

Raymond G Fenwick

from Laguna Niguel, CA
Age ~82
Get Report
Also known as:
Raymond George Fenwick, Raynond George Fenwick, Ray G Fenwick
Related to:
Barbara L Purnell, 78Julie L Zygutis, 60Semetrica RobertsChristopher HendersonDannon HendersonSally Benaglio
Connected to:
Alexander J Fenwick, 36Autumn Fenwick, 29Brenda R Fenwick, 53Brent S Fenwick, 48Brigitta M Fenwick, 69Carrie G Fenwick, 53Chelsea L Fenwick, 36Clara E Fenwick, 63Conner K Fenwick, 32Crystal Fenwick, 49

Raymond Fenwick Phones & Addresses

  • Laguna Niguel, CA
  • 42048 Crestview Cir, Northville, MI 48167
  • Houston, TX
  • 3859 Wisteria Cir, Sugar Land, TX 77479
  • Amherst, MA
  • Farmington Hills, MI
  • Westford, MA

Work

Position: Retired

Education

Degree: Doctorates, Doctor of Philosophy Specialities: Philosophy

Skills

Infectious Diseases • Molecular Biology • Laboratory • Clinical Research • Lifesciences • Biotechnology • Oncology • Clinical Trials • Immunology • Healthcare • Laboratory Medicine

Industries

Hospital & Health Care

Resumes

Resumes

Raymond Fenwick Photo 1

Retired

View page
Location:
Laguna Niguel, CA
Industry:
Hospital & Health Care
Work:

Retired
Quest Diagnostics Feb 1996 - Apr 2008
Scientific Direstor
Biodale Laboratories Sep 1994 - Jan 1996
Vice President Scientific Development
Skills:
Infectious Diseases
Molecular Biology
Laboratory
Clinical Research
Lifesciences
Biotechnology
Oncology
Clinical Trials
Immunology
Healthcare
Laboratory Medicine

Publications

Us Patents

Cystic Fibrosis Transmembrane Conductance Regulator Gene Mutations

View page
US Patent:
7794937, Sep 14, 2010
Filed:
Dec 22, 2006
Appl. No.:
11/615645
Inventors:
Weimin Sun - Irvina CA, US
Matthew J. McGinniss - San Diego CA, US
Donghui Huang - Irvine CA, US
Arlene Buller - Rancho Santa Margarita CA, US
Raymond Fenwick - Laguna Niguel CA, US
Mei Peng - Irvine CA, US
Franklin Quan - Rancho Santa Margarita CA, US
Assignee:
Quest Diagnostics Investments Incorporated - Wilmington DE
International Classification:
C12Q 1/66
C12P 19/34
US Classification:
435 6, 435 912, 536 235, 536 2431
Abstract:
The present invention provides novel mutations of the CFTR gene related to cystic fibrosis or to conditions associated with cystic fibrosis. Also provided are probes for detecting the mutant sequences. Methods of identifying if an individual has a genotype containing one or more mutations in the CFTR gene are further provided.

Cystic Fibrosis Transmembrane Conductance Regulator Gene Mutations

View page
US Patent:
7820388, Oct 26, 2010
Filed:
Nov 9, 2007
Appl. No.:
11/938138
Inventors:
Weimin Sun - Irvina CA, US
Matthew J. McGinniss - San Diego CA, US
Donghui Huang - Irvine CA, US
Arlene Buller - Rancho Santa Margarita CA, US
Raymond Fenwick - Laguna Niguel CA, US
Mei Peng - Irvine CA, US
Franklin Quan - Rancho Santa Margarita CA, US
Assignee:
Quest Diagnostics Investments Incorporated - Wilmington DE
International Classification:
C12Q 1/66
C12P 19/34
US Classification:
435 6, 435 912, 536 235, 536 2431
Abstract:
The present invention provides novel mutations of the CFTR gene related to cystic fibrosis or to conditions associated with cystic fibrosis. Also provided are probes for detecting the mutant sequences. Methods of identifying if an individual has a genotype containing one or more mutations in the CFTR gene are further provided.

Cystic Fibrosis Transmembrane Conductance Regulator Gene Mutations

View page
US Patent:
8124345, Feb 28, 2012
Filed:
Jul 30, 2010
Appl. No.:
12/847960
Inventors:
Weimin Sun - Irvine CA, US
Matthew J. McGinniss - San Diego CA, US
Donghui Huang - Irvine CA, US
Arlene Buller - Rancho Santa Margarita CA, US
Raymond Fenwick - Laguna Niguel CA, US
Mei Peng - Irvine CA, US
Franklin Quan - Rancho Santa Margarita CA, US
Assignee:
Quest Diagnostics Investments Incorporated - Wilmington DE
International Classification:
C12Q 1/68
C07H 21/04
C12P 19/34
US Classification:
435 611, 435 912, 435 612, 536 243
Abstract:
The present invention provides novel mutations of the CFTR gene related to cystic fibrosis or to conditions associated with cystic fibrosis. Also provided are probes for detecting the mutant sequences. Methods of identifying if an individual has a genotype containing one or more mutations in the CFTR gene are further provided.

Methods Of Determining Genotypes In Duplicated Genes And Genomic Regions

View page
US Patent:
20040209259, Oct 21, 2004
Filed:
Apr 16, 2003
Appl. No.:
10/417804
Inventors:
Raymond Fenwick - Laguna Niguel CA, US
Assignee:
Quest Diagnostics Investments Incorporated
International Classification:
C12Q001/68
C12P019/34
US Classification:
435/006000, 435/091200
Abstract:
The present invention provides methods of determining the genotype at a duplicated region of a genome. The methods involve (a) amplifying the DNA, preferably using four amplification primers The exemplary methods produce a first amplicon corresponding to a first distinct region or gene by utilizing a first primer and a second primer which are selected to produce the first amplicon in the presence of the first distinct region or gene, but not in absence of the first distinct region or gene. A second amplicon corresponding to a second distinct region or gene is also produced by utilizing a third primer and a fourth primer which are selected to produce the second amplicon in the presence of the second distinct region or gene, but not in the absence of the second distinct region or gene. A third and/or fourth amplicon corresponding to a hybrid gene or genes is/are also produced if a hybrid gene is present.

Cystic Fibrosis Transmembrane Conductance Regulator Gene Mutations

View page
US Patent:
20120141996, Jun 7, 2012
Filed:
Jan 25, 2012
Appl. No.:
13/358322
Inventors:
Weimin Sun - Irvine CA, US
Matthew J. McGinniss - San Diego CA, US
Donghui Huang - San Ramon CA, US
Arlene Buller - Rancho Santa Margarita CA, US
Raymond Fenwick - Laguna Niguel CA, US
Mei Peng - Irvine CA, US
Franklin Quan - Rancho Santa Margarita CA, US
International Classification:
C12Q 1/68
G01N 33/566
US Classification:
435 611, 435 71
Abstract:
The present invention provides novel mutations of the CFTR gene related to cystic fibrosis or to conditions associated with cystic fibrosis. Also provided are probes for detecting the mutant sequences. Methods of identifying if an individual has a genotype containing one or more mutations in the CFTR gene are further provided.

Cystic Fibrosis Transmembrane Conductance Regulator Gene Mutations

View page
US Patent:
20200270687, Aug 27, 2020
Filed:
Dec 9, 2019
Appl. No.:
16/707584
Inventors:
- Secaucus NJ, US
Matthew J. McGinniss - San Diego CA, US
Donghui Huang - San Ramon CA, US
Arlene Buller - Rancho Santa Margarita CA, US
Raymond Fenwick - Laguna Niguel CA, US
Mei Peng - Irvine CA, US
Franklin Quan - Rancho Santa Margarita CA, US
Assignee:
Quest Diagnostics Investments LLC - Secaucus NJ
International Classification:
C12Q 1/6883
G01N 33/68
Abstract:
The present invention provides novel mutations of the CFTR gene related to cystic fibrosis or to conditions associated with cystic fibrosis. Also provided are probes for detecting the mutant sequences. Methods of identifying if an individual has a genotype containing one or more mutations in the CFTR gene are further provided.

Cystic Fibrosis Transmembrane Conductance Regulator Gene Mutations

View page
US Patent:
20180195129, Jul 12, 2018
Filed:
Mar 2, 2018
Appl. No.:
15/910681
Inventors:
- Wilmington DE, US
Matthew J. McGinniss - San Diego CA, US
Donghui Huang - San Ramon CA, US
Arlene Buller - Rancho Santa Margarita CA, US
Raymond Fenwick - Laguna Niguel CA, US
Mei Peng - Irvine CA, US
Franklin Quan - Rancho Santa Margarita CA, US
Assignee:
Quest Diagnostics Investments Incorporated - Wilmington DE
International Classification:
C12Q 1/6883
G01N 33/68
Abstract:
The present invention provides novel mutations of the CFTR gene related to cystic fibrosis or to conditions associated with cystic fibrosis. Also provided are probes for detecting the mutant sequences. Methods of identifying if an individual has a genotype containing one or more mutations in the CFTR gene are further provided.

Cystic Fibrosis Transmembrane Conductance Regulator Gene Mutations

View page
US Patent:
20170002418, Jan 5, 2017
Filed:
Jul 18, 2016
Appl. No.:
15/212581
Inventors:
- Wilmington DE, US
Matthew J. McGinniss - San Diego CA, US
Donghui Huang - San Ramon CA, US
Arlene Buller - Rancho Santa Margarita CA, US
Raymond Fenwick - Laguna Niguel CA, US
Mei Peng - Irvine CA, US
Franklin Quan - Rancho Santa Margarita CA, US
Assignee:
Quest Diagnostics Investments Incorporated - Wilmington DE
International Classification:
C12Q 1/68
G01N 33/68
Abstract:
The present invention provides novel mutations of the CFTR gene related to cystic fibrosis or to conditions associated with cystic fibrosis. Also provided are probes for detecting the mutant sequences. Methods of identifying if an individual has a genotype containing one or more mutations in the CFTR gene are further provided.
Control profile
Raymond G Fenwick from Laguna Niguel, CA, age ~82 Get Report